Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.

Journal of Toxicology, published by HINDAWI LTD, stands as a pivotal open-access journal in the fields of toxicology and pharmacology since its inception in 2009. With an ISSN of 1687-8191 and an E-ISSN of 1687-8205, this journal is dedicated to disseminating high-quality research that critically examines the effects of toxic substances on living organisms. Located in Egypt and operating from their London office, it aims to provide an extensive platform for researchers worldwide to share findings that can inform better practices in safety and regulation. As of 2023, it has achieved significant recognition, holding a Q3 ranking in both the pharmacology and toxicology categories, and is indexed in Scopus with noteworthy percentile rankings (Toxicology: 57th and Pharmacology: 55th). With a focus on innovative studies and emerging areas such as environmental toxicology, biomarker research, and therapeutic interventions, the Journal of Toxicology invites both experienced researchers and students to contribute, thereby enhancing the breadth and depth of toxicological knowledge for the global scientific community.

The Digest Journal of Nanomaterials and Biostructures, published by VIRTUAL CO PHYSICS SRL, is a premier open-access journal since 2006, focusing on the dynamic intersections of nanotechnology, biostructures, and material science. Based in Romania, this journal caters to a diverse readership of researchers, professionals, and students in fields such as nanoscience, biomedical engineering, and condensed matter physics. Despite its current Q4 ranking in multiple categories, including Atomic and Molecular Physics and Structural Biology, the journal serves as a valuable platform for disseminating innovative research and fostering collaboration across scientific disciplines. The journal’s commitment to open access ensures that groundbreaking findings in nanomaterials are readily available to a global audience, reflecting the increasing importance of interdisciplinary research in addressing contemporary challenges. With its ongoing evolution and the potential for high-impact contributions to the scientific community, Digest Journal of Nanomaterials and Biostructures plays a crucial role in advancing knowledge and innovation in its respective fields.

Cancer Nanotechnology is a cutting-edge peer-reviewed journal dedicated to advancing the field of cancer research through innovative nanotechnology applications. Published by SPRINGER WIEN, this open-access journal, established in 2010, provides a vital platform for the dissemination of high-quality research with a focus on the intersection of nanotechnology, oncology, and biomedical engineering. With a commitment to promoting accessibility and fostering collaboration, Cancer Nanotechnology has gained impressive rankings within specialized categories, including Q2 in Biomedical Engineering and Pharmaceutical Science. The journal's rigorous selection process ensures that only the most impactful studies reach its audience, making it a must-read for researchers, professionals, and students eager to explore the latest advancements and methodologies in cancer treatment. With its scope encompassing critical topics that bridge multiple disciplines—including physical chemistry and toxicology—Cancer Nanotechnology positions itself as an influential resource for shaping the future of cancer therapies.

ChemNanoMat is a prestigious academic journal published by WILEY-V C H VERLAG GMBH, dedicated to the rapidly evolving fields of nanoscale materials and their applications in diverse areas such as biomaterials, energy engineering, and environmental sustainability. With the journal's ISSN 2199-692X and recognized quality, as evidenced by its Q2 rankings across multiple categories—including Biomaterials and Renewable Energy—ChemNanoMat serves as a crucial platform for researchers, professionals, and students to disseminate their findings and foster collaborations. Operating from Germany, the journal encourages the exploration of innovative materials solutions to meet tomorrow's challenges. While it does not currently offer open access options, it remains highly regarded in the academic community with a competitive impact factor that emphasizes its relevance and influence in guiding future research directions. Covering a broad scope from 2015 through 2024, ChemNanoMat is key for anyone invested in the advancement of materials chemistry and related scientific fields.

TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY is a pivotal journal published by Taylor & Francis Ltd, addressing critical intersections between environmental chemistry and toxicology since its inception in 1979. With its ISSN 0277-2248 and E-ISSN 1029-0486, the journal serves as a platform for rigorous research and innovative methodologies in pollution control, health implications of environmental chemicals, and the broader spectrum of toxicological studies. Although it currently does not offer open access, the journal's impact in the field is underscored by its Category Quartiles rankings in 2023, placing it in Q3 across Environmental Chemistry, Health, Toxicology and Mutagenesis, and Pollution categories. Furthermore, its Scopus rankings reveal its significant role within the scientific community, specifically in areas such as Environmental Science and Toxicology. The journal aspires to foster multidisciplinary dialogue and advance knowledge that contributes to environmental sustainability and public health, making it an essential resource for researchers, professionals, and students dedicated to these fields.

Toxin Reviews is a premier academic journal focused on the critical field of Toxicology, published by Taylor & Francis Inc. Established with an aim to foster research and disseminate knowledge, this journal has been pivotal since its inception in 1982 and continues to be a leading platform for both emerging and established researchers. With an impressive impact factor and ranked in the 75th percentile among its peers in the Scopus categories, it serves as an essential resource for scientists, practitioners, and students interested in understanding the complexities of toxins and their effects on health. The journal provides an Open Access platform, enhancing visibility and accessibility of research findings to a broader audience. Covering a wide scope, Toxin Reviews plays a vital role in bridging gaps between toxicological research and practical applications, ensuring that rigorous scientific inquiry translates into real-world solutions.

Artificial Cells Nanomedicine and Biotechnology is a prestigious peer-reviewed journal published by TAYLOR & FRANCIS LTD, specializing in the rapidly evolving fields of biomedical engineering, biotechnology, and nanomedicine. Established in 2013 and operating under an open-access model since 2019, the journal aims to bridge the gap between fundamental science and real-world medical applications, showcasing cutting-edge research that advances our understanding of artificial cells and their biotechnological applications. With an impressive impact factor and ranking in the Q2 quartile across various categories, including Biomedical Engineering, Medicine, and Pharmaceutical Sciences, the journal is a leading platform for innovative studies that contribute significantly to the realm of healthcare and therapeutic development. Researchers, professionals, and students alike will find invaluable insights and advancements within its pages, positioning it as a vital resource for those dedicated to pushing the boundaries of science and improving patient outcomes.

Current Nanoscience is a prominent journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of nanoscience through the dissemination of high-quality research and review articles. Since its inception in 2006, the journal has provided a platform for innovative studies across a variety of related disciplines, including bioengineering, biomedical engineering, biotechnology, and nanotechnology, reflecting its diverse scope and interdisciplinary nature. With a Q3 ranking in several categories such as Biomedical Engineering and Pharmaceutical Science and a Scopus percentile ranking around the 60th in its field, Current Nanoscience serves as a vital resource for researchers and professionals seeking to stay abreast of the latest developments and breakthroughs. Although it operates without an open access model, the journal maintains a commitment to enhancing accessibility and relevance in the scientific community. The editorial team is focused on publishing articles that address both theoretical and practical aspects of nanoscience, ensuring that the findings contribute to knowledge and innovation in areas critical to technology and healthcare.

JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, published by Taylor & Francis Ltd, is a distinguished scholarly journal dedicated to the exploration of biomaterials and their applications in various fields such as bioengineering, biomedical engineering, and biophysics. With an ISSN of 0920-5063 and an E-ISSN of 1568-5624, this journal offers a platform for researchers and professionals to share innovative findings and methodologies that advance the science of polymer-based biomaterials. The journal's impact within the academic community is underscored by its notable Scopus rankings, including a Q2 status in both Biomedical Engineering and Biophysics as of 2023, reflecting its significant contribution to advancing knowledge and practice in these fields. The scope of the journal spans from fundamental research to applications in medical devices and regenerative medicine, ensuring comprehensive coverage of the latest trends and breakthroughs. Although it does not currently offer open access options, the journal remains a pivotal resource for students, researchers, and professionals committed to the development and application of biomaterials in healthcare. For further details, the journal is based in Abingdon, United Kingdom, at 2-4 Park Square, Milton Park, OX14 4RN.